Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment

See what CB Insights has to offer


Biz Plan Competition | Alive

Total Raised


Last Raised

$110K | 10 yrs ago

About LEMM Technologies

LEMM Technologies is developing non-invasive devices that perform sensitive blood chemistry analysis. LEMM will initially target the U.S. at home blood glucose monitor market. LEMM Technologies' exclusive invention SubtleSense uses the near infrared (NIR) portion of the electromagnetic spectrum to measure the concentration of glucose in the body non-invasively. This is accomplished by exposing NIR light across a novel body compartment.

LEMM Technologies Headquarter Location

West Lafayette, Indiana,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LEMM Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LEMM Technologies is included in 2 Expert Collections, including Diabetes.



1,750 items


Health Monitoring & Diagnostics

905 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.